GlaxoSmithKline Bangladesh Ltd
GLAXOSMITH · Dhaka Stock Exchange (DSE) · Pharmaceuticals / Healthcare
About the company
GlaxoSmithKline Bangladesh is the listed subsidiary of GSK PLC in Bangladesh, manufacturing and marketing a range of prescription medicines, vaccines, and consumer healthcare products. It is one of the highest-margin pharmaceutical stocks on the DSE in terms of return on equity. The company has periodically repatriated large special dividends to shareholders.
| Exchange | Dhaka Stock Exchange (DSE) |
| Ticker | GLAXOSMITH |
| Sector | Pharmaceuticals / Healthcare |
| Indicative market cap USD | $75.00M |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (Dhaka Stock Exchange (DSE)), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Dhaka Stock Exchange — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Bangladesh
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.